Evidence map›Paper›PMID 27918854›Full record

Trial reportNutrition and cancer2017

Randomized Trial Testing the Effects of Eating Frequency on Two Hormonal Biomarkers of Metabolism and Energy Balance.

Martine M Perrigue, Adam Drewnowski, Ching-Yun Wang, Xiaoling Song, Mario Kratz, Marian L Neuhouser

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition and cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Martine M Perriguea Cancer Prevention Program , Fred Hutchinson Cancer Research Center , Seattle , Washington , USA.
Adam Drewnowskib Nutritional Sciences Program , School of Public Health, University of Washington , Seattle , Washington , USA.
Ching-Yun Wanga Cancer Prevention Program , Fred Hutchinson Cancer Research Center , Seattle , Washington , USA.
Xiaoling Songa Cancer Prevention Program , Fred Hutchinson Cancer Research Center , Seattle , Washington , USA.
Mario Kratza Cancer Prevention Program , Fred Hutchinson Cancer Research Center , Seattle , Washington , USA.
Marian L Neuhousera Cancer Prevention Program , Fred Hutchinson Cancer Research Center , Seattle , Washington , USA.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Cancer Prevention Trng-Nutrition, Exercise &GeneticsR25CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2002 to 2016
$7.3M
NCI NIH HHS P30 CA015704NCI NIH HHS R25 CA094880
6 · The paper itself

Abstract

backgroundEating frequency (EF) may influence obesity-related disease risk by attenuating postprandial fluctuations in hormones involved in metabolism, appetite regulation, and inflammation. MATERIALS/

methodsThis randomized crossover intervention trial tested the effects of EF on fasting plasma insulin-like growth factor-I (IGF-1) and leptin. Fifteen subjects (4 males, 11 females) completed two eucaloric intervention phases lasting 21 days each: low EF ("low-EF"; 3 eating occasions/day) and high EF ("high-EF"; 8 eating occasions/day). Subjects were free-living and consumed their own meals using individualized structured meal plans with instruction from study staff. Subjects completed fasting blood draws and anthropometry on the first and last day of each study phase. The generalized estimated equations modification of linear regression tested the intervention effect on fasting serum IGF-1 and leptin.

resultsMean (± SD) age was 28.5 ± 8.70 years, and mean (± SD) Body Mass Index was 23.3 (3.4) kg/m

conclusionThese results suggest that increased EF may lower serum IGF-1, which is a hormonal biomarker linked to increased risk of breast, prostate, and colorectal cancer.

Indexed as

Feeding BehaviorAdultBiomarkersBody Mass IndexEnergy MetabolismFemaleHumansInsulin-Like Growth Factor ILeptinLinear ModelsMaleBiomarkersInsulin-Like Growth Factor ILeptin

Identifiers

PMID27918854
PMCPMC5204366
OpenAlexW2560249836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.